AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Xgeva market forecast points to long-term growth
AGP
The Business Research Company says the Xgeva market is expanding on rising bone metastasis cases, broader oncology use and growing demand for bone-targeted therapies.
Xeomin market forecast points to growth through 2030
AGP
The Business Research Company says the Xeomin market is poised for continued expansion through 2030, driven by wider medical uses, growing demand for non-surgical cosmetic treatments and advances in toxin formulations.
Xolair market seen expanding through 2030 as asthma cases rise
AGP
The Business Research Company says the global Xolair market is set to grow through 2030, driven by rising asthma and allergic disease rates, wider biologic use and greater demand for personalized treatment.
Vyvgart market outlook improves as autoimmune demand rises
AGP
The Business Research Company says the Vyvgart market is set for further growth as autoimmune disease cases climb and use of FcRn inhibitors expands.
Xiaflex market gains on rising demand for non-surgical treatment
AGP
The Xiaflex market is expanding as more patients and doctors turn to non-surgical care for Dupuytren’s contracture and Peyronie’s disease.
WinRho market growth driven by ITP demand and healthcare spending
AGP
The WinRho SD market is expanding on steady use in immune thrombocytopenia, Rh prophylaxis and other blood-disorder care, according to a new 2026 report from The Business Research Company.
Yervoy market seen rising to $9.93 million by 2030
AGP
The Business Research Company says the Yervoy market is on track for steady growth through 2030, driven by rising cancer cases, broader immunotherapy use and more combination treatments.
Xembify market outlook flags growth from immune disorder demand
AGP
The Business Research Company says the Xembify market is expanding as diagnosis rates for primary immunodeficiency diseases rise and healthcare spending climbs.
Vyvgart Hytrulo market seen growing on autoimmune demand and personalized medicine
AGP
The Business Research Company says the Vyvgart Hytrulo market is poised for expansion as generalized myasthenia gravis diagnoses rise and subcutaneous biologics gain favor.
Wilate market report sees steady growth through 2026
AGP
The Business Research Company says the Wilate market is expanding on rising bleeding-disorder diagnoses, higher healthcare spending and broader use of home infusion and plasma-derived therapies.
Xenpozyme market gains traction as rare disease treatment evolves
AGP
The Business Research Company says the Xenpozyme market is expanding as rare disease diagnosis, personalized medicine and healthcare infrastructure improve.
Cold pain therapy market forecast to hit $2.65 billion by 2030
AGP
The cold pain therapy market is projected to grow from $1.87 billion in 2025 to $2.65 billion by 2030, according to The Business Research Company.
Vyjuvek market forecast points to long-term growth as gene therapy use expands
AGP
The Business Research Company says the Vyjuvek market is positioned for sustained expansion through 2035 as gene delivery technology, rare disease research and regulatory support broaden the use of topical gene therapies.
Vpriv market forecast points to growth in rare disease therapy
AGP
The Vpriv market is expanding on stronger diagnosis rates, broader access to rare disease treatments and rising investment in personalized medicine.
Vimizim market forecast points to steady growth through 2035
AGP
The Business Research Company says the market for Vimizim (elosulfase alfa), an enzyme replacement therapy for Morquio A syndrome, is expanding on better diagnosis, rising rare-disease awareness and more spending on specialty care.
Unituxin market forecast points to growth through 2035
AGP
The Business Research Company says the Unituxin market is set for steady expansion through 2035, driven by rising cancer cases, higher healthcare spending and more R&D in pediatric oncology.
Verluma market forecast points to growth in cancer imaging demand
AGP
The Business Research Company says the Verluma market is expanding on the back of rising cancer cases, more diagnostic imaging, and stronger healthcare spending.
Compression bandages market to reach $2.24 billion by 2030
AGP
The compression bandages market is projected to grow from $1.73 billion in 2025 to $1.84 billion in 2026, according to The Business Research Company.
Compression stockings market to reach $2.45 billion by 2030
AGP
The global compression stockings market is projected to grow from $1.87 billion in 2025 to $1.99 billion in 2026, then climb to $2.45 billion by 2030, according to The Business Research Company.
Compound management market to hit $1.2 billion by 2030
AGP
The compound management market is forecast to grow from $0.61 billion in 2025 to $1.2 billion by 2030, driven by pharmaceutical R&D, digital tracking and outsourced research.
Sign up for:
Market Forecast Analysis
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.